JP2021519063A5 - - Google Patents

Info

Publication number
JP2021519063A5
JP2021519063A5 JP2020551300A JP2020551300A JP2021519063A5 JP 2021519063 A5 JP2021519063 A5 JP 2021519063A5 JP 2020551300 A JP2020551300 A JP 2020551300A JP 2020551300 A JP2020551300 A JP 2020551300A JP 2021519063 A5 JP2021519063 A5 JP 2021519063A5
Authority
JP
Japan
Prior art keywords
population
cells
proportion
marker
expressed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020551300A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519063A (ja
Filing date
Publication date
Priority claimed from GBGB1804701.9A external-priority patent/GB201804701D0/en
Application filed filed Critical
Publication of JP2021519063A publication Critical patent/JP2021519063A/ja
Publication of JP2021519063A5 publication Critical patent/JP2021519063A5/ja
Priority to JP2024020808A priority Critical patent/JP2024073435A/ja
Pending legal-status Critical Current

Links

JP2020551300A 2018-03-23 2019-03-25 異種ターゲティング構築物を発現するリンパ球 Pending JP2021519063A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024020808A JP2024073435A (ja) 2018-03-23 2024-02-15 異種ターゲティング構築物を発現するリンパ球

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1804701.9 2018-03-23
GBGB1804701.9A GB201804701D0 (en) 2018-03-23 2018-03-23 Lymphocytes expressing heterologous targeting constructs
PCT/EP2019/057469 WO2019180279A1 (en) 2018-03-23 2019-03-25 Lymphocytes expressing heterologous targeting constructs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024020808A Division JP2024073435A (ja) 2018-03-23 2024-02-15 異種ターゲティング構築物を発現するリンパ球

Publications (2)

Publication Number Publication Date
JP2021519063A JP2021519063A (ja) 2021-08-10
JP2021519063A5 true JP2021519063A5 (cg-RX-API-DMAC7.html) 2022-03-30

Family

ID=62068083

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020551300A Pending JP2021519063A (ja) 2018-03-23 2019-03-25 異種ターゲティング構築物を発現するリンパ球
JP2024020808A Pending JP2024073435A (ja) 2018-03-23 2024-02-15 異種ターゲティング構築物を発現するリンパ球

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024020808A Pending JP2024073435A (ja) 2018-03-23 2024-02-15 異種ターゲティング構築物を発現するリンパ球

Country Status (15)

Country Link
US (1) US20210015867A1 (cg-RX-API-DMAC7.html)
EP (2) EP3768696B1 (cg-RX-API-DMAC7.html)
JP (2) JP2021519063A (cg-RX-API-DMAC7.html)
KR (1) KR20220029292A (cg-RX-API-DMAC7.html)
CN (1) CN112513067A (cg-RX-API-DMAC7.html)
AU (2) AU2019239705B9 (cg-RX-API-DMAC7.html)
BR (1) BR112020019143A2 (cg-RX-API-DMAC7.html)
CA (1) CA3094766A1 (cg-RX-API-DMAC7.html)
EA (1) EA202092261A1 (cg-RX-API-DMAC7.html)
GB (1) GB201804701D0 (cg-RX-API-DMAC7.html)
IL (2) IL277517B2 (cg-RX-API-DMAC7.html)
MX (3) MX2020009859A (cg-RX-API-DMAC7.html)
MY (1) MY208877A (cg-RX-API-DMAC7.html)
PH (1) PH12020551538A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019180279A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114651003A (zh) 2019-09-10 2022-06-21 黑曜石疗法公司 用于可调调节的ca2-il15融合蛋白
GB202013962D0 (en) 2020-09-04 2020-10-21 Gammadelta Therapeutics Ltd Immunotherapy composition
CN115381965B (zh) * 2022-09-01 2023-03-14 广东龄值生物科技有限公司 一种γδT细胞功能化的磁性微球、制备方法及其用途
WO2026019861A1 (en) * 2024-07-15 2026-01-22 Adicet Therapeutics, Inc. METHODS FOR EXPANDING γδ T CELL POPULATIONS

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
DE69233482T2 (de) 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
WO1993011794A1 (en) 1991-12-13 1993-06-24 Xoma Corporation Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
GB9203459D0 (en) 1992-02-19 1992-04-08 Scotgen Ltd Antibodies with germ-line variable regions
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
US5786464C1 (en) 1994-09-19 2012-04-24 Gen Hospital Corp Overexpression of mammalian and viral proteins
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US6114148C1 (en) 1996-09-20 2012-05-01 Gen Hospital Corp High level expression of proteins
CN1294148C (zh) 2001-04-11 2007-01-10 中国科学院遗传与发育生物学研究所 环状单链三特异抗体
CA2531118C (en) 2003-07-01 2013-01-08 Immunomedics, Inc. Multivalent carriers of bi-specific antibodies
EP1660186B1 (en) 2003-08-18 2013-12-25 MedImmune, LLC Humanization of antibodies
US20050042664A1 (en) 2003-08-22 2005-02-24 Medimmune, Inc. Humanization of antibodies
EP1786918A4 (en) 2004-07-17 2009-02-11 Imclone Systems Inc NEW BISPECIFIC ANTIBODY TETRAVALENT
KR20140053410A (ko) 2005-08-19 2014-05-07 아보트 러보러터리즈 이원 가변 도메인 면역글로불린 및 이의 용도
US8940707B2 (en) 2010-10-28 2015-01-27 Viropharma Incorporated Maribavir isomers, compositions, methods of making and methods of using
EP2710123B1 (en) 2011-05-19 2017-07-12 Instituto de Medicina Molecular Cell line of lymphocytes comprising gamma-delta t cells, composition and production method thereof
GB201506423D0 (en) * 2015-04-15 2015-05-27 Tc Biopharm Ltd Gamma delta T cells and uses thereof
RU2756247C2 (ru) 2014-11-17 2021-09-28 Эдисет Био, Инк. Генетически модифицированные гамма дельта т-клетки
GB201507368D0 (en) * 2015-04-30 2015-06-17 Ucl Business Plc Cell
JP6799895B2 (ja) 2015-06-09 2020-12-16 リンファクト−リンフォサイト アクティベイション テクノロジーズ エス.エー. TCRγδ+T細胞の生産方法
CN108473958A (zh) 2015-10-30 2018-08-31 癌症研究技术有限公司 非造血组织驻留γδT细胞的扩增及这些细胞的用途
JP6976960B2 (ja) * 2015-11-27 2021-12-08 カーサリクス プロプライエタリー リミテッド 遺伝子改変された細胞およびその使用
WO2017190100A1 (en) * 2016-04-28 2017-11-02 The Trustees Of Dartmouth College Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof
CN118421557A (zh) 2016-05-12 2024-08-02 阿迪塞特治疗公司 选择性扩增γδT细胞群的方法及其组合物
EP3487991B1 (en) * 2016-07-25 2022-09-07 The United States of America, as represented by The Secretary, Department of Health and Human Services Methods of producing modified natural killer cells and methods of use
GB201707048D0 (en) 2017-05-03 2017-06-14 King S College London Expansion of gamma delta cells, compositions, and methods of use thereof

Similar Documents

Publication Publication Date Title
Phan et al. Stock return forecasting: Some new evidence
JP2013516431A5 (cg-RX-API-DMAC7.html)
JP2015158565A5 (cg-RX-API-DMAC7.html)
EP4235549A3 (en) Rapid distributed consensus on blockchain
JP2020507222A5 (cg-RX-API-DMAC7.html)
JP2023506251A5 (cg-RX-API-DMAC7.html)
CN110198739A (zh) 一种pd-l1抗体药物组合物及其用途
JP2018501356A5 (cg-RX-API-DMAC7.html)
JP2019212805A5 (cg-RX-API-DMAC7.html)
JP2015505089A5 (cg-RX-API-DMAC7.html)
JP2014063186A5 (cg-RX-API-DMAC7.html)
JP2014525395A5 (cg-RX-API-DMAC7.html)
MX2016014241A (es) Composicion de limpieza que contiene una polieteramina.
MX2016000003A (es) Metodo y aparato para generar, a partir de una representacion de dominio de coeficiente de señales hoa, una representacion de dominio mixto espacial/coeficiente de dichas señales hoa.
Ji et al. Effective spreading from multiple leaders identified by percolation in the susceptible-infected-recovered (SIR) model
JP2015041624A5 (cg-RX-API-DMAC7.html)
JP2023532185A5 (cg-RX-API-DMAC7.html)
JP2012084862A5 (cg-RX-API-DMAC7.html)
JP2017528470A5 (cg-RX-API-DMAC7.html)
WO2020086362A3 (en) Relativistic quantum computer / quantum gravity computer
JP2024507779A5 (cg-RX-API-DMAC7.html)
EP3999696C0 (en) GYPSUM INTERLOCKING SURFACE BUILDING PRODUCTS, MANUFACTURING METHODS
WO2015150431A3 (fr) Plaque de coffrage pour murs ou voûtes
JP2019506134A5 (cg-RX-API-DMAC7.html)
Hao et al. The pessimistic diagnosabilities of some general regular graphs